2. Introduction
Characterized by:
Premature RBC destruction (less than the normal 120-day lifespan).
Elevated erythropoietin with increased erythropoiesis.
Increased hemoglobin catabolites (e.g., bilirubin)
Excess serum bilirubin is unconjugated.
Ultimate levels of hyperbilirubinemia depend on:
liver functional capacity
Rate of hemolysis
Normal liver severe jaundice rarely.
3. Contd
BM erythropoiesis unable to compensate for degree
of destruction of red cells Anaemia develops.
Clinical and lab findings indicates:
Accelerated destruction of red cells.
Compensatory marrow regeneration.
Mild hemolysis compensatory BM function adequate
No manifestation of anaemia Compensated
hemolytic anaemia.
4. Classification
Location of hemolysis: Intravascular and
extravascular.
Source of defect causing hemolysis:
Intracorpuscular defect and extracorpuscular
defect
Mode of onset: Hereditary and acquired
disorders.
Underlying mechanisms of hemolysis: Immune
or Non-immune.
7. Red Cells Destruction
Extra-vascular Hemolysis
Normal site of destruction
of old RBCs: Spleen (80-
90%).
In HA This mechanism
Exaggerated.
Intra-vascular Hemolysis
RBCs in circulation get
destroyed release of Hb
in plasma.
Main pathway of: PNH.
10. Extravascular hemolysis
Occurs in macrophages of the spleen (and other organs).
Predisposing factors:
RBC membrane injury
Reduced deformability
Opsonization
Principal clinical features are:
Anemia, splenomegaly, and jaundice
Modest reductions in haptoglobin
a serum protein that binds hemoglobin
11. Contd
Increased unconjugated bilirubin: jaundice.
Increased stercobilinogen: dark colored stool.
Increased urobilinogen: high colored urine.
Increased iron store: iron released from heme
stored in BM.
13. Contd
Characteristic findings of intra-vascular
hemolysis:
Hemoglobinemia
Haemoglobinuria
Haemosiderinuria
S. Heptoglobin: decreased
14. Laboratory Findings
Increase S. Bilirubun (Unconjugated).
Increase Urine Urobilinogen.
Increase rate of Bilirubin production.
Increase S. LDH.
Decrease life span of red cells.
Decrease Heptoglobin.
15. Clinical Manifestations
Clinical signs & symptoms depends upon:
Severity of hemolysis.
Duration of hemolysis.
Manifestaions mostly seen in Chronic HA:
Pallor
Jaundice
Splenomegaly
Gall stones
Skeletal abnormalities
Leg ulcers
16. Compensatory Mechanisms To Hemolysis
BM Erythroid hyperplasia:
Chronic hemolysis --> Anaemia --> Increase in
Erythropoietin --> BM erythroid hyperplasia.
Reversal of M:E ratio. (2-4:1 --> 1:1-6).
Reticulocytosis:
BM erythroid hyperplasia --> rise in Reticulocytes.
Mild: Hemoglobinopathies.
Moderate to marked: IHA, HS, G6PD def.
17. Peripheral Blood Findings
Polychromatophilia:
Large red cells released
from BM.
Corresponds to
reticulocytes.
Nucleated RBC (nRBC):
Seen in moderate to
marked anaemia.
Neutrophilia:
Active moderate to
marked hemolysis.
Neutrophilia with shift
to left (metamyelocyte,
Myelocytes).
Thrombocytosis:
Acute hemolysis
Numerous and large
platelets.
18. Morphologic Red Cell Abnormalities
Provide clue to the underlying hemolytic
conditions.
Spherocytes
Sickle cells
Target Cells
Schistocytes
Acanthocytes
19. Fig: Marrow aspirate smear from a patient with hemolytic anemia. There is an
increased number of maturing erythroid progenitors (normoblasts).
22. Hereditory Spherocytosis
D/t cytoskeletal or membrane protein defects.
Render RBCs spheroidal and less deformable
Vulnerable to splenic sequestration and
destruction.
AD in 75% of patients.
23. Pathogenesis
Insufficiency in several different proteins: spectrin, ankyrin,
band 3, or band 4.2.
Lead to reduced density of membrane skeletal components
Reduced stability of the lipid bilayer.
Loss of membrane fragments as RBCs age.
Reduction in surface area
RBCs assume a spheroidal shape.
Diminished deformability.
Propensity for being trapped and destroyed by splenic macrophages.
25. Fig: Reduced membrane stability in HS --> loss of RBC membrane -->
formation of microspherocytes --> Ingested by splenic Macrophages.
27. Morphology
Spherocytic RBCs are small and lack central
pallor.
Reticulocytosis and marrow erythroid
hyperplasia.
Marked splenic congestion with prominent
erythrophagocytosis in the cords of Billroth.
29. Clinical Features
Diagnosis depends on: family history, hematologic findings,
and increased RBC osmotic fragility
MCHC increased: d/t cellular dehydration.
Characteristic: Anemia, moderate splenomegaly, and jaundice.
Clinical course: typically stable due to compensatory increases
in erythropoiesis.
Increased RBC turnover or diminished erythropoiesis can be
problematic.